Back to Market返回行情
ID
IDIA.SW Idorsia Ltd
SIXHealthcare$4.52+1.21%ClosedMarket Cap: $970.8M
As of 2026-06-01 06:35
Valuation
P/E (TTM)
-5.17
PEG
—
P/B
-0.97
P/S
4.43
EV/EBITDA
-15.29
DCF Value
—
FCF Yield
-14.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
87.9%
Operating Margin
-95.6%
Net Margin
-100.7%
ROE
19.2%
ROA
-45.9%
ROIC
-62.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $57.4M | 86.0% | $-26.5M | $-45.7M | $-0.18 | — |
| Q4 2025 | $48.0M | 89.0% | $-135.8M | $-78.0M | $-0.31 | — |
| Q3 2025 | $41.5M | 76.3% | $-44.7M | $-85.7M | $-0.40 | — |
| Q2 2025 | $72.2M | 95.3% | $-2.5M | $-11.4M | $-0.06 | — |
| Q1 2025 | $58.9M | 95.9% | $66.7M | $63.1M | $0.23 | — |
| Q4 2024 | $59.9M | 12.2% | $-78.3M | $-84.0M | $-0.45 | — |
| Q3 2024 | $26.2M | -97.5% | $-89.6M | $-101.0M | $-0.55 | — |
| Q2 2024 | $16.3M | 69.1% | $-97.1M | $-108.6M | $-0.60 | — |
| Q1 2024 | $10.1M | 26.7% | $-94.6M | $29.9M | $0.13 | — |
| Q4 2023 | $21.5M | 79.3% | $-114.6M | $-116.7M | $-0.65 | — |
| Q3 2023 | $79.9M | 98.2% | $230.8M | $224.0M | $0.96 | — |
| Q2 2023 | $29.9M | 85.4% | $-177.0M | $-193.1M | $-1.03 | — |